机译:氯环嗪通过直接靶向HCV包膜糖蛋白1来抑制丙型肝炎病毒进入的病毒融合
Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health;
Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health;
Division of Pre-Clinical Innovations National Center for Advancing Translational Sciences National Institutes of Health;
Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health;
Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health;
Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health;
Li Ka Shing Virology Institute University of Alberta;
Division of Pre-Clinical Innovations National Center for Advancing Translational Sciences National Institutes of Health;
Advanced Mass Spectrometry Facility National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health;
Division of Pre-Clinical Innovations National Center for Advancing Translational Sciences National Institutes of Health;
Advanced Mass Spectrometry Facility National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health;
Division of Pre-Clinical Innovations National Center for Advancing Translational Sciences National Institutes of Health;
Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health;
viral infection; fusion peptide; drug resistance-associated substitutions; photo-activated cross-linking; membrane fusion; molecular modeling; viral hepatitis; antiviral development; vaccine;
机译:氯环嗪通过直接靶向HCV包膜糖蛋白1来抑制丙型肝炎病毒进入的病毒融合
机译:丙型肝炎病毒(HCV)包膜糖蛋白E1和E2含有对病毒进入必需的降低的半胱氨酸残基
机译:1型人类T细胞白血病病毒包膜糖蛋白的抗体可强有力地激活细胞介导的细胞毒性反应,并在进入过程的多个步骤中直接中和病毒感染性。
机译:通过使用LCX PCR系统测试,同时提取人免疫缺陷病毒类型1(HIV-1)和丙型肝炎病毒(HCV)RNA,不会损害两种病毒的病毒载量的测量
机译:HCV包膜假型病毒颗粒的开发,用于评估HCV包膜加工中涉及的HCV进入抑制剂和细胞蛋白酶。
机译:使用反式互补系统对丙型肝炎病毒(HCV)信封蛋白E1进行功能分析揭示了推定的E1融合肽在HCV进入和形态发生中的双重作用
机译:丙型肝炎病毒(HCV)包膜糖蛋白E1和E2含有减少的半胱氨酸残基,对于病毒进入来说必不可少*
机译:可用于治疗牛病毒性腹泻病毒(BVDV)感染和丙型肝炎病毒(HCV)感染的化合物,方法和组合物。